BDBM199539 (1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]nonan-7-yl 1-(1h-pyrazol-4-yl)- 1h-indole-3-carboxylate::US10125145, Cpd. No. 29::US9670229, 29

SMILES CN1C2COCC1CC(C2)OC(=O)c1cn(-c2cn[nH]c2)c2ccccc12

InChI Key

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 199539   

Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199539((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]nona...)
Affinity DataIC50:  0.462nMAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199539((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]nona...)
Affinity DataIC50:  0.462nMT: 2°CAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent